---
title: "This Faeth Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294519780.md"
description: "Wall Street analysts initiated coverage on five stocks with bullish outlooks. Baird rated Heartflow (HTFL) Outperform ($34 PT); Roth Capital rated Sky Harbour (SKYH) Buy ($14 PT); Raymond James rated Faeth Therapeutics (FTH) Outperform ($56 PT); Cantor Fitzgerald rated Duos Technologies (DUOT) Overweight ($26 PT); and Citigroup rated BBB Foods (TBBB) Buy ($49 PT)."
datetime: "2026-07-31T13:12:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294519780.md)
  - [en](https://longbridge.com/en/news/294519780.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294519780.md)
generator: "portal-rs"
---

# This Faeth Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   Baird analyst David Rescott initiated coverage on **Heartflow Inc** (NASDAQ:HTFL) with an Outperform rating and announced a price target of $34. HeartFlow closed at $25.83 on Thursday. See how other analysts view this stock.
-   Roth Capital analyst Tom Hayes initiated coverage on **Sky Harbour Group Corp** (NYSE:SKYH) with a Buy rating and announced a price target of $14. Sky Harbour shares closed at $10.48 on Thursday. See how other analysts view this stock.
-   Raymond James analyst Sean McCutcheon initiated coverage on **Faeth Therapeutics, Inc** (NASDAQ:FTH) with an Outperform rating and announced a price target of $56. Faeth Therapeutics closed at $28.82 on Thursday. See how other analysts view this stock.
-   Cantor Fitzgerald analyst Brett Knoblauch initiated coverage on **Duos Technologies Group Inc** (NASDAQ:DUOT) with an Overweight rating and announced a price target of $26. Duos Technologies shares closed at $8.14 on Thursday. See how other analysts view this stock.
-   Citigroup analyst Renata Cabral initiated coverage on **BBB Foods Inc** (NYSE:TBBB) with a Buy rating and announced a price target of $49. BBB Foods shares closed at $40.20 on Thursday. See how other analysts view this stock.

Considering buying FTH stock? Here’s what analysts think:

*Photo via Shutterstock*

### Related Stocks

- [FTH.US](https://longbridge.com/en/quote/FTH.US.md)
- [DUOT.US](https://longbridge.com/en/quote/DUOT.US.md)
- [SKYH.US](https://longbridge.com/en/quote/SKYH.US.md)
- [HTFL.US](https://longbridge.com/en/quote/HTFL.US.md)
- [TBBB.US](https://longbridge.com/en/quote/TBBB.US.md)
- [SKYH+.US](https://longbridge.com/en/quote/SKYH+.US.md)

## Related News & Research

- [BBB Foods director Reich Sapire Rose Nicole Dominique disposes of 7,623 shares worth $388,773](https://longbridge.com/en/news/298766953.md)
- [Heartflow CFO Vikram Verghese disposes of 6,640 common shares for $332,211.72](https://longbridge.com/en/news/298647129.md)
- [BBB Foods director Reich Sapire Rose Nicole Dominique reports sale of 7,623 common shares worth $384,961.5](https://longbridge.com/en/news/298073504.md)
- [Heartflow CFO Vikram Verghese disposes of USD 1.67 million in common shares](https://longbridge.com/en/news/298077815.md)
- [Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | FTH Stock News](https://longbridge.com/en/news/297318443.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**